Evidence map›Paper›PMID 23066834›Full record

ArticleMolecular microbiology2012

A role for topoisomerase III in Escherichia coli chromosome segregation.

Brenda A Perez-Cheeks, Chong Lee, Ryo Hayama, Kenneth J Marians

Erratum issuedAbstract read
In one paragraph

Article in Molecular microbiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. The regulation of DNA supercoiling across evolution.Protein science : a publication of the Protein Society · 2021
    Review
  8. Lytic bacteriophages facilitate antibiotic sensitization ofAntimicrobial agents and chemotherapy · 2021
    Article
  9. The many lives of type IA topoisomerases.The Journal of biological chemistry · 2020
    Review
  10. Review
  11. Article
  12. Direct observation of topoisomerase IA gate dynamics.Nature structural & molecular biology · 2018
    Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

4 authors.

Brenda A Perez-CheeksMolecular Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Chong Lee
Ryo Hayama
Kenneth J Marians

Funding

Topoisomerases, Condensins, and Chromosome SegregationR01GM034558 · NIGMS · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI MARIANS, KENNETH J · 1985 to 2017
$6.6M
NIGMS NIH HHS GM34558NIGMS NIH HHS R01 GM034558
6 · The paper itself

Abstract

The cellular function of Escherichia coli topoisomerase III remains elusive. We show that rescue of temperature-sensitive mutants in parE and parC (encoding the subunits of the chromosomal decatenase topoisomerase IV) at restrictive temperatures by high-copy suppressors is strictly dependent on topB (encoding topoisomerase III). Double mutants of parEΔtopB and parCΔtopB were barely viable, grew slowly, and were defective in chromosome segregation at permissive temperatures. The topB mutant phenotype did not result from accumulation of toxic recombination intermediates, because it was not relieved by mutations in either recQ or recA. In addition, in an otherwise wild-type genetic background, ΔtopB cells treated with the type II topoisomerase inhibitor novobiocin displayed aberrant chromosome segregation. This novobiocin sensitivity was attributable to an increased demand for topoisomerase IV and is unlikely to define a new role for topoisomerase III; therefore, these results suggest that topoisomerase III participates in orderly and efficient chromosome segregation in E. coli.

Indexed as

Chromosome SegregationAnti-Bacterial AgentsDNA Topoisomerase IVDNA Topoisomerases, Type IEnzyme InhibitorsEscherichia coliGene DeletionNovobiocinAnti-Bacterial AgentsDNA Topoisomerase IVDNA Topoisomerases, Type IEnzyme InhibitorsNovobiocin

Identifiers

PMID23066834
PMCPMC3549057

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.